H&K selected for new Tylenol med

NEW YORK: The McNeil Consumer Healthcare Division of Johnson & Johnson has chosen Hill & Knowlton over a host of suitors for the launch of its new liquid Tylenol Sore Throat medicine.

NEW YORK: The McNeil Consumer Healthcare Division of Johnson & Johnson has chosen Hill & Knowlton over a host of suitors for the launch of its new liquid Tylenol Sore Throat medicine.

NEW YORK: The McNeil Consumer Healthcare Division of Johnson &

Johnson has chosen Hill & Knowlton over a host of suitors for the launch

of its new liquid Tylenol Sore Throat medicine.



The new product, billed by the company as the first over-the-counter

medication for sore throat pain relief, will start appearing on store

shelves across the country this week.



Aside from the Tylenol launch, H&K is also coordinating a sore throat

education campaign jointly sponsored by McNeil and the American Academy

of Otolaryngology, a physician’s organization dedicated to the care of

ears, nose and throat.



The agency boasts a fairly extensive history with both McNeil and parent

company Johnson & Johnson. It is currently directing a global program in

support of the McNeil division’s Benecol cholesterol-lowering foods.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.